Abstract: PO0210
AKI!Now: Defining Excellence in the Prevention of and Care for Patients with AKI
Session Information
- AKI: Epidemiology, Risk Factors, and Prevention
November 04, 2021 | Location: On-Demand, Virtual Only
Abstract Time: 10:00 AM - 12:00 PM
Category: Acute Kidney Injury
- 101 AKI: Epidemiology, Risk Factors, and Prevention
Authors
- Cerda, Jorge, Albany Medical College, Albany, New York, United States
- Parikh, Samir M., Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
- Koyner, Jay L., University of Chicago Pritzker School of Medicine, Chicago, Illinois, United States
- Vijayan, Anitha, Washington University in St Louis, St Louis, Missouri, United States
- Goldstein, Stuart, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- Liu, Kathleen D., University of California San Francisco, San Francisco, California, United States
- Ostermann, Marlies, Guy's and St Thomas' NHS Foundation Trust, London, London, United Kingdom
- Agarwal, Anupam, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, United States
- Okusa, Mark D., University of Virginia Medical Center, Charlottesville, Virginia, United States
Group or Team Name
- AKI!Now Initiative of the American Society of Nephrology
Background
ASN is committed to define excellence in AKI prevention and care to transform management, reduce morbidity, mortality and improve long-term outcomes. AKI!Now addresses a set of well-defined objectives to achieve those goals.
Methods
The AKI!Now initiative has developed a broad education program that bridges the continuum from basic investigation to clinical studies focused on early recognition, intervention, and effective therapies with a patient-centered focus
Results
Workgroups and tasks: Basic Science: AKI-Specific Early Interventions: Leverage basic science discoveries to innovate in AKI prevention, diagnosis, and treatment; develop a centralized research portal; promote AKI research and translational initiatives; create a roadmap to facilitate discovery and novel interventions; and enhance communication within the community. AKI Recognition and Clinical Interventions: Artificial Intelligence (AI): Design fair and equitable AI tools among physicians and researchers; and provide expert input on pathways to implement AI tools in all clinical contexts. Post-AKI Recovery: Identify mechanisms of repair to identify treatment strategies to accelerate recovery; prevent adverse outcomes and identify areas of priority research; promote comparative effectiveness research benchmarks; develop, test, and promote strategies to build capacity for post-AKI care. Public Awareness and Education: Leverage existing and develop novel education processes for health professionals and patients and multiple resources including the AKI!Now Compendium, focusing on AKI recognition, management, and recovery; collaboratively emphasize the role of continuous quality improvement in AKI recognition and care, and include patients and families in the healing process.
Conclusion
AKI is common, serious, under-recognized across the life span, and associated with severe risk of progressive adverse outcomes. Education at all levels; use of AI to improve pattern recognition, prevention, and management; development of novel specific therapies through better understanding of AKI mechanisms; and appropriate post-AKI recovery care will alleviate the severe short- and long-term individual and societal AKI impacts.